Latest Interest Rates News

Babylon Pump & Power has initiated a $12.7 million rights issue at a 37.5% discount to restore working capital, reduce debt, and expand its water management rental fleet, aiming to lift its ASX trading suspension.

WAM Income Maximiser (ASX: WMX) has lifted its fully franked monthly dividends for Q4 2026, pushing the annualised yield to 7.1% including franking credits, supported by a robust 17.8% per annum portfolio return since inception and notably lower volatility than the ASX 300.

Aldoro Resources has secured A$4.3 million through unsecured convertible notes, providing funding to accelerate development at its Kameelburg Critical Minerals Project and exploring a potential Hong Kong Stock Exchange listing.

Venari Minerals has raised an oversubscribed $6.1 million to fund key development stages at its Red Mountain Lithium and Strategic Minerals Project in Nevada, including resource upgrades and a scoping study targeted for early 2027.

FBR has locked in a binding agreement for an initial $900,000 convertible note issue, with options to raise up to $3.87 million subject to shareholder approval and other conditions. The funds will support general working capital as the company explores a confidential acquisition opportunity.

WAM Income Maximiser has posted a 19.2% investment portfolio gain for the year ended June 2026, outperforming its benchmark by 13.4% with notably lower volatility, while increasing fully franked dividends to an annualised yield of 6.9%.

International Equities Corporation Ltd (ASX:IEQ) posted a modest profit for the June 2026 quarter, reversing prior losses amid a challenging economic backdrop that forced the company to exit its hotel and tourism activities.

AMP Limited has lifted its underlying net profit after tax (NPAT) guidance for the first half of 2026 to $170 million-$180 million, driven by stronger China partnerships and recognition of carried interest from legacy asset sales.

Neurotech International has locked in a $3.15 million secured loan against its anticipated R&D tax incentives to fund pivotal Phase III autism trials and ongoing operations.

Keybridge Capital Limited confirms ongoing financial support from WAM Active and outlines plans to meet overdue reporting obligations ahead of a potential ASX delisting.

City Chic Collective (ASX: CCX) reports a robust FY26 underlying EBITDA rise of 80%-95%, driven by strong ANZ sales and tight cost control amid a slight global revenue decline.

Mesoblast Limited’s Ryoncil® posted US$36 million in Q4 revenue, driving a full-year total of US$115 million, exceeding initial forecasts. The FDA-approved stem cell therapy for pediatric graft-versus-host disease shows robust uptake across US pediatric centres.